Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

Malaria remains a major cause of morbidity and mortality in Africa, particularly in children under five years of age. Availability of effective anti-malarial drug treatment is a cornerstone for malaria control and eventual malaria elimination. Artemisinin-based combination therapy (ACT) is worldwide...

Descripció completa

Dades bibliogràfiques
Autors principals:	Tindana, P, de Haan, F, Amaratunga, C, Dhorda, M, van der Pluijm, RW, Dondorp, AM, Cheah, PY
Format:	Journal article
Idioma:	English
Publicat:	BioMed Central 2021

Ítems similars

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
per: Paulina Tindana, et al.
Publicat: (2021-02-01)

Triple artemisinin-based combination therapies for malaria – a new paradigm?
per: van der Pluijm, RW, et al.
Publicat: (2020)

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
per: Paulina Tindana, et al.
Publicat: (2022-01-01)

Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study
per: Freek de Haan, et al.
Publicat: (2022-04-01)

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol. [version 1; peer review: 2 approved]
per: Paulina Tindana, et al.
Publicat: (2021-04-01)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
per: van der Pluijm, RW, et al.
Publicat: (2022)

Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling
per: Dini, S, et al.
Publicat: (2018)

Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
per: Emmanuel Kokori, et al.
Publicat: (2024-01-01)

Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
per: Freek de Haan, et al.
Publicat: (2023-09-01)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
per: Nguyen, TD, et al.
Publicat: (2023)

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
per: Freek de Haan, et al.
Publicat: (2021-01-01)

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype
per: Ansbro, MR, et al.
Publicat: (2020)

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
per: Van Anh Thi Cao, et al.
Publicat: (2023-10-01)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
per: Tran Dang Nguyen, et al.
Publicat: (2023-07-01)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
per: Rosemonde M. Guissou, et al.
Publicat: (2023-09-01)

Everyday Aesthetic Practices, Ethics and Tact
per: Ossi Naukkarinen
Publicat: (2014-06-01)

Everyday Aesthetic Practices, Ethics and Tact
per: Ossi Naukkarinen
Publicat: (2014-06-01)

Artemisinin-resistant malaria in Africa demands urgent action
per: Dhorda, M, et al.
Publicat: (2024)

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
per: Miotto, O, et al.
Publicat: (2020)

Artemisinin resistance in falciparum malaria
per: Dondorp, A
Publicat: (2012)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
per: Peto, TJ, et al.
Publicat: (2022)

Experiences, perceptions and ethical considerations of the malaria infection study in Thailand
per: Naemiratch, B, et al.
Publicat: (2025)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
per: Zhu, L, et al.
Publicat: (2022)

Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? – A review of guidelines in non-endemic countries
per: Visser, MT, et al.
Publicat: (2022)

TACT Design
per: John Bradley
Publicat: (1996-05-01)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
per: Dondorp, A, et al.
Publicat: (2009)

Spread of artemisinin resistance in Plasmodium falciparum malaria.
per: Ashley, E, et al.
Publicat: (2014)

Antimalarial mass drug administration: ethical considerations
per: Cheah, PY, et al.
Publicat: (2016)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
per: Tun, KM, et al.
Publicat: (2018)

The threat of artemisinin-resistant malaria.
per: Dondorp, A, et al.
Publicat: (2011)

Artemisinin resistance and stage dependency of parasite clearance in Falciparum malaria
per: Intharabut, B, et al.
Publicat: (2019)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
per: Zhu, L, et al.
Publicat: (2018)

The mechanism of artemisinin resistance of Plasmodium falciparum malaria parasites originates in their initial transcriptional response
per: Zhu, L, et al.
Publicat: (2021)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
per: Zhu, Lei, et al.
Publicat: (2019)

The digital geographies of tact
per: Mike Duggan
Publicat: (2024-12-01)

How to contain artemisinin- and multidrug-resistant Falciparum malaria
per: Dondorp, A, et al.
Publicat: (2017)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
per: Lei Zhu, et al.
Publicat: (2018-12-01)

Avec tact et délicatesse...
per: Yvelyne Fumat
Publicat: (2001-01-01)

Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance
per: Mok, S., et al.
Publicat: (2016)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
per: Zhu, Lei, et al.
Publicat: (2022)